Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03245762 · ClinicalTrials.gov registry record · Phase 1
Intranasal Oxytocin for Infants With Prader-Willi Syndrome
A Phase 1 study, sponsored by University of Florida.
- Completed
- Registry status
- Phase 1
- Development phase
- 15
- Enrollment target
NCT03245762 is a Phase 1 study that has completed, run by University of Florida. The registered enrollment target is 15 participants.
The verdict
NCT03245762, a Phase 1 study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 15 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the change in suck and swallow competency from baseline to morning of day 6 with intranasal oxytocin spray vs placebo in infants/children with Prader-Willi Syndrome who are in nutritional phase 1a. Videofluoroscopic swallow studies will be performed on treatment day 1 and on the day following treatment morning of day 6.
Interventions
- DRUG Placebo
- DRUG Oxytocin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2017-08-01 |
| Est. Completion | 2018-01-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03245762
The ClinicalTrials.gov registry entry for NCT03245762 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03245762 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03245762 about?
NCT03245762 is a clinical study titled "Intranasal Oxytocin for Infants With Prader-Willi Syndrome". The purpose of this study is to compare the change in suck and swallow competency from baseline to morning of day 6 with intranasal oxytocin spray vs placebo in infants/children with Prader-Willi Syndrome who are in nutritional phase 1a. Videofluoroscopic swallow studies will be performed on treatme...
What is the current status of trial NCT03245762?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 15 participants. The study started on 2017-08-01. Estimated completion is 2018-01-04.
What interventions are being tested in trial NCT03245762?
The interventions under investigation include: Placebo (DRUG), Oxytocin (DRUG).
Who is sponsoring clinical trial NCT03245762?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.